TICRYNAFEN Struktur

Tienilinsure

Bezeichnung:Tienilinsure

CAS-Nr40180-04-9

Englisch Name:TICRYNAFEN

CBNumberCB8500854

SummenformelC13H8Cl2O4S

Molgewicht331.17

MOL-Datei40180-04-9.mol

Synonyma

Tienilinsure

Tienilinsure physikalisch-chemischer Eigenschaften

Schmelzpunkt	148-149oC
Siedepunkt	534.6±50.0 °C(Predicted)
Dichte	1.532
storage temp.	-20°C
Löslichkeit	DMSO: soluble5mg/mL (clear solution)
Aggregatzustand	powder
pka	2.79±0.10(Predicted)
Farbe	white to beige

Sicherheit

Kennzeichnung gefährlicher	Xn
R-Sätze:	22
WGK Germany	3
RTECS-Nr.	AG9300000
Toxizität	LD50 in mice (mg/kg): 225 i.v., 1275 orally (US 3758506)

Gefahreninformationscode (GHS)

TICRYNAFEN Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung
Cytochrome P450 enzymes function to metabolize both endogenous and exogenous compounds. Both the 3A and 2C isoforms are present in human liver of which CYP2C9 seems most highly expressed. Tienilic acid is a specific suicide substrate for CYP2C9 and CYP2C10 whereby its oxidation inactivates the enzyme. The time required to inactivate one half of the CYP2C10 enzyme at the maximal rate (t_½max) is 3.4 minutes, with a dissociation constant (KI) value of 4.3 μM.
Chemische Eigenschaften
Pale Beige Solid
Verwenden
A heterocycloc derivative of phenoxyacetic Acid. Uses as a diuretic, uricosuric, anhtihypertensive
Verwenden
Tienilic Acid is a heterocyclic derivative of phenoxyacetic acid. Tienilic acid is used as diuretic, uricosuric, antihypertensive.
Definition
ChEBI: An aromatic ketone that is 2,3-dichlorophenoxyacetic acid in which the hydrogen at position 4 on the benzene ring is replaced by a thiophenecarbonyl group. A loop diuretic used to treat hypertension, it was withdrawn from the market in 1982 due to links wi h hepatitis.
Trademarks
Tienilic Acid is INN and BAN;Anp 3624;Diflarex;Fr 3068;Selcryn;Skf-62698;Ticrynafen;Ticrynapen.
Weltgesundheitsorganisation (WHO)
Tienilic acid, a diuretic agent with uricosuric and antihypertensive activity, was introduced in 1976. By 1979 its use had been associated with cases of hepatic toxicity, some of which were fatal, which led to the withdrawal of the drug in most countries in which it was marketed. In France, however, precautions regarding the use of tienilic acid were issued by the Pharmacovigilance Commission and the drug remained available for another decade. In 1991, it was eventually also withdrawn there since cases of hepatitis, some of which were fulminant, had continued to occur.
Biochem/physiol Actions
Tienilic Acid (Ticrynafen) is a P450 inhibitor, a specific suicide substrate for CYP2C9 and CYP2C10. It was once used as a loop diuretic drug with uric acid-lowering (uricosuric) actvity, but was removed from market because of hepatotoxicity.

Tienilinsure Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

40180-04-9, TICRYNAFEN Verwandte Suche:

Send Inquriy